Brindha Pillay1, Addie C Wootten2, Helen Crowe3, Niall Corcoran3, Ben Tran4, Patrick Bowden5, Jane Crowe6, Anthony J Costello2. 1. Epworth Prostate Centre, Epworth Healthcare, Richmond, Victoria, Australia. Electronic address: brindha.pillay@epworth.org.au. 2. Epworth Prostate Centre, Epworth Healthcare, Richmond, Victoria, Australia; Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia; Australian Prostate Cancer Research, North Melbourne, Victoria, Australia. 3. Epworth Prostate Centre, Epworth Healthcare, Richmond, Victoria, Australia; Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia. 4. Department of Medical Oncology, Royal Melbourne Hospital, Parkville, Victoria, Australia. 5. Radiation Oncology, Epworth Healthcare, Richmond, Victoria, Australia. 6. Epworth Prostate Centre, Epworth Healthcare, Richmond, Victoria, Australia.
Abstract
BACKGROUND: Conducting regular multidisciplinary team (MDT) meetings requires significant investment of time and finances. It is thus important to assess the empirical benefits of such practice. A systematic review was conducted to evaluate the literature regarding the impact of MDT meetings on patient assessment, management and outcomes in oncology settings. METHODS: Relevant studies were identified by searching OVID MEDLINE, PsycINFO, and EMBASE databases from 1995 to April 2015, using the keywords: multidisciplinary team meeting* OR multidisciplinary discussion* OR multidisciplinary conference* OR case review meeting* OR multidisciplinary care forum* OR multidisciplinary tumour board* OR case conference* OR case discussion* AND oncology OR cancer. Studies were included if they assessed measurable outcomes, and used a comparison group and/or a pre- and post-test design. RESULTS: Twenty-seven articles met inclusion criteria. There was limited evidence for improved survival outcomes of patients discussed at MDT meetings. Between 4% and 45% of patients discussed at MDT meetings experienced changes in diagnostic reports following the meeting. Patients discussed at MDT meetings were more likely to receive more accurate and complete pre-operative staging, and neo-adjuvant/adjuvant treatment. Quality of studies was affected by selection bias and the use of historical cohorts impacted study quality. CONCLUSIONS: MDT meetings impact upon patient assessment and management practices. However, there was little evidence indicating that MDT meetings resulted in improvements in clinical outcomes. Future research should assess the impact of MDT meetings on patient satisfaction and quality of life, as well as, rates of cross-referral between disciplines.
BACKGROUND: Conducting regular multidisciplinary team (MDT) meetings requires significant investment of time and finances. It is thus important to assess the empirical benefits of such practice. A systematic review was conducted to evaluate the literature regarding the impact of MDT meetings on patient assessment, management and outcomes in oncology settings. METHODS: Relevant studies were identified by searching OVID MEDLINE, PsycINFO, and EMBASE databases from 1995 to April 2015, using the keywords: multidisciplinary team meeting* OR multidisciplinary discussion* OR multidisciplinary conference* OR case review meeting* OR multidisciplinary care forum* OR multidisciplinary tumour board* OR case conference* OR case discussion* AND oncology OR cancer. Studies were included if they assessed measurable outcomes, and used a comparison group and/or a pre- and post-test design. RESULTS: Twenty-seven articles met inclusion criteria. There was limited evidence for improved survival outcomes of patients discussed at MDT meetings. Between 4% and 45% of patients discussed at MDT meetings experienced changes in diagnostic reports following the meeting. Patients discussed at MDT meetings were more likely to receive more accurate and complete pre-operative staging, and neo-adjuvant/adjuvant treatment. Quality of studies was affected by selection bias and the use of historical cohorts impacted study quality. CONCLUSIONS: MDT meetings impact upon patient assessment and management practices. However, there was little evidence indicating that MDT meetings resulted in improvements in clinical outcomes. Future research should assess the impact of MDT meetings on patient satisfaction and quality of life, as well as, rates of cross-referral between disciplines.
Authors: Ohad Ronen; K Thomas Robbins; Remco de Bree; Orlando Guntinas-Lichius; Dana M Hartl; Akihiro Homma; Avi Khafif; Luiz P Kowalski; Fernando López; Antti A Mäkitie; Wai Tong Ng; Alessandra Rinaldo; Juan P Rodrigo; Alvaro Sanabria; Alfio Ferlito Journal: Eur Arch Otorhinolaryngol Date: 2021-05-12 Impact factor: 2.503
Authors: Antonella Colasante; Antonietta Augurio; Raffaella Basilico; Antonio Raffaele Cotroneo; Maria B Di Sciascio; Giuseppe Gaspari; Domenico Genovesi; Jamara Giampietro; Romina Iantorno; Antonio Marchetti; Clara Natoli; Antonello Nuzzo; Floriana Ottaviani; Paolo Pompa; Pietro Castellan; Raffaele Tenaglia; Annamaria Vinciguerra Journal: Oncol Lett Date: 2017-11-30 Impact factor: 2.967
Authors: Stefano Botti; Iris Agreiter; Laura Orlando; Gianpaolo Gargiulo; Francesca Bonifazi; Marina Marialuisa Banfi; Lorella Cappucciati; Cristiana Caffarri; Valentina De Cecco; Giuseppe Marco Deiana; Marta Gavezzotti; Antonio Magarò; Maria Giovanna Netti; Adriana Concetta Pignatelli; Elena Rostagno; Emanuela Samarani; Janini Silva Cardoso; Sonia Soave; Concetta Maria Valente; Alessio Vedovetto; Marco Zecca; Stefano Luminari; Francesco Merli; Monica Guberti Journal: Support Care Cancer Date: 2020-02-13 Impact factor: 3.603